The abstract is read at the publisher; the summary is JClub's.
GLP-1 receptor agonists are linked to thyroid C-cell hyperplasia and neoplasia in dose-dependent rodent studies, but primate and human data do not show C-cell stimulation.
- Why it matters: Rodent findings prompted an FDA boxed warning restricting GLP-1RAs in patients with personal or family medullary thyroid carcinoma history or Multiple Endocrine Neoplasia, yet human relevance was uncertain.
- What they did: The review compares preclinical rodent oncogenicity with primate studies and human evidence from randomized trials, cohort analyses using administrative/EMR/registry data, and pharmacovigilance database signal detection.
- The result: Most clinical and meta-analytic data report no clear association with thyroid cancer development, while pharmacovigilance suggests a possible signal likely influenced by reporting bias, implying the boxed warning may no longer be necessary.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.